Skip to Content
Merck
  • Adrenocorticotropin-corticosterone relationship during dexamethasone therapy in 17 alpha-hydroxylase deficiency.

Adrenocorticotropin-corticosterone relationship during dexamethasone therapy in 17 alpha-hydroxylase deficiency.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme (1992-07-01)
A C Moreira, A M Leal, M Castro
ABSTRACT

A previous study in an untreated girl with 17 alpha-hydroxylase deficiency syndrome (17-OHDS) indicated that in the absence of cortisol production, ACTH and corticosterone (B) may interact to modulate the brain-pituitary-adrenocortical system. The ACTH-B interplay was further examined in this patient under dexamethasone therapy and after withdrawal of treatment. Plasma ACTH and B were highly correlated (r = 0.89) during two different schedules of dexamethasone treatment and two weeks off treatment at all blood sampling times (morning, afternoon or 24-h period). A logarithmic-sigmoidal relationship seems to exist between ACTH and B secretion. The time course of ACTH-B relationship early after withdrawal of therapy showed good parallelism between these two variables. Plasma B may be a useful guide for monitoring therapy in 17-OHDS. The present study also indicates the ACTH-B interplay feedback set-points.

MATERIALS
Product Number
Brand
Product Description

Dexamethasone isonicotinate, European Pharmacopoeia (EP) Reference Standard
Dexamethasone isonicotinate for impurity C identification, European Pharmacopoeia (EP) Reference Standard